| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Magnetic Resonance Unit (Drs. Meyerhoff and Weiner, and C. Bloomer) and Psychiatry Research (C. Bloomer, and Drs. Cardenas and Fein), Department of Veterans Affairs Medical Center; and the Departments of Radiology (Drs. Meyerhoff, Cardenas, Norman, and Weiner), Medicine (Dr. Weiner), and Psychiatry (Drs. Weiner and Fein), University of California San Francisco, CA.
Address correspondence and reprint requests to Dr. Dieter J. Meyerhoff, MR Unit, DVA Medical Center, 4150 Clement Street (114M), San Francisco, CA 94121; e-mail: djmey{at}itsa.ucsf.edu
OBJECTIVE: To determine whether the concentrations of the neuronal marker N-acetylaspartate (NAA) and the choline-containing metabolites (Cho) are altered in the subcortical brain of HIV+ patients who are cognitively normal and clinically asymptomatic, and to determine whether these alterations are greater in the presence of cognitive impairments and clinical symptoms.
BACKGROUND: Pathologic studies suggest that subcortical gray matter carries a heavy HIV load, and neuropsychological test results are consistent with involvement of subcortical and frontostriatal brain systems in HIV disease. Noninvasive proton magnetic resonance spectroscopy (1H MRS) suggests neuronal preservation and macrophage infiltration in the subcortical brain of clinically symptomatic and cognitively impaired HIV+ individuals. Improved 1H MRS methods may allow the early detection of metabolite alterations in the subcortical brain of asymptomatic HIV+ individuals.
METHODS: Two-dimensional 1H MRS imaging was performed on 30 HIV- control subjects and 70 HIV+ patients with varying severities of systemic disease and neuropsychological impairments, but without cerebral opportunistic infections.
RESULTS: Subcortical Cho was elevated in HIV+ patients compared with control subjects regardless of the presence or absence of cognitive impairment or clinical symptoms. Subcortical NAA was lower than control NAA only in severely cognitively impaired HIV+ subjects. Subcortical NAA correlated with performance on a variety of neuropsychological tests but not with Centers for Disease Control clinical stage, whereas high-thalamic Cho was associated with low CD4 lymphocyte counts.
CONCLUSIONS: 1H MRS imaging detects higher Cho in subcortical brain early in HIV disease, when individuals are clinically and neuropsychologically asymptomatic, whereas lower NAA is only found in subcortical brain in individuals with severe neuropsychological impairments. Quantitative 1H MRS imaging may play a role in the objective assessment of the presence, magnitude, and progression of brain involvement in HIV infection.
This article has been cited by other articles:
|
|
 |
|
  J. Wilkinson, M. Radkowski, and T. Laskus Hepatitis C Virus Neuroinvasion: Identification of Infected Cells J. Virol., February 1, 2009; 83(3): 1312 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Petrou, R.E. Harris, B.R. Foerster, S.A. Mclean, A. Sen, D.J. Clauw, and P.C. Sundgren Proton MR Spectroscopy in the Evaluation of Cerebral Metabolism in Patients with Fibromyalgia: Comparison with Healthy Controls and Correlation with Symptom Severity AJNR Am. J. Neuroradiol., May 1, 2008; 29(5): 913 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Roc, B. M. Ances, S. Chawla, M. Korczykowski, R. L. Wolf, D. L. Kolson, J. A. Detre, and H. Poptani Detection of Human Immunodeficiency Virus Induced Inflammation and Oxidative Stress in Lenticular Nuclei With Magnetic Resonance Spectroscopy Despite Antiretroviral Therapy Arch Neurol, September 1, 2007; 64(9): 1249 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Paul, C. T. Yiannoutsos, E. N. Miller, L. Chang, C. M. Marra, G. Schifitto, T. Ernst, E. Singer, T. Richards, G. J. Jarvik, et al. Proton MRS and Neuropsychological Correlates in AIDS Dementia Complex: Evidence of Subcortical Specificity J Neuropsychiatry Clin Neurosci, August 1, 2007; 19(3): 283 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D M Forton Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition? Gut, November 1, 2006; 55(11): 1535 - 1537. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Gabis, A. Belman, Wei Huang, M. Milazzo, and S. Nachman Clinical and Imaging Study of Human Immunodeficiency Virus-1--Infected Youth Receiving Highly Active Antiretroviral Therapy: Pilot Study Using Magnetic Resonance Spectroscopy J Child Neurol, June 1, 2006; 21(6): 485 - 490. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Potula, J. Haorah, B. Knipe, J. Leibhart, J. Chrastil, D. Heilman, H. Dou, R. Reddy, A. Ghorpade, and Y. Persidsky Alcohol Abuse Enhances Neuroinflammation and Impairs Immune Responses in an Animal Model of Human Immunodeficiency Virus-1 Encephalitis Am. J. Pathol., April 1, 2006; 168(4): 1335 - 1344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Chang, T. Ernst, O. Speck, and C. S. Grob Additive Effects of HIV and Chronic Methamphetamine Use on Brain Metabolite Abnormalities Am J Psychiatry, February 1, 2005; 162(2): 361 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Paul, T. P. Flanigan, K. Tashima, R. Cohen, J. Lawrence, E. Alt, D. Tate, C. Ritchie, and C. Hinkin Apathy Correlates With Cognitive Function But Not CD4 Status in Patients With Human Immunodeficiency Virus J Neuropsychiatry Clin Neurosci, February 1, 2005; 17(1): 114 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Ragin, P. Storey, B. A. Cohen, R. R. Edelman, and L. G. Epstein Disease burden in HIV-associated cognitive impairment: A study of whole-brain imaging measures Neurology, December 28, 2004; 63(12): 2293 - 2297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Keller, T. N. Venkatraman, A. Thomas, A. Deveikis, C. LoPresti, J. Hayes, N. Berman, I. Walot, S. Padilla, J. Johnston-Jones, et al. Altered neurometabolite development in HIV-infected children: Correlation with neuropsychological tests Neurology, May 25, 2004; 62(10): 1810 - 1817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Patel, M. Inglese, G. Glosser, D. L. Kolson, R. I. Grossman, and O. Gonen Whole-Brain N-Acetylaspartate Level and Cognitive Performance in HIV Infection AJNR Am. J. Neuroradiol., September 1, 2003; 24(8): 1587 - 1591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Wenserski, H.-J. von Giesen, H.-J. Wittsack, A. Aulich, and G. Arendt Human Immmunodeficiency Virus 1-associated Minor Motor Disorders: Perfusion-weighted MR Imaging and H MR Spectroscopy Radiology, July 1, 2003; 228(1): 185 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ge, D. L. Kolson, J. S. Babb, L. J. Mannon, and R. I. Grossman Whole Brain Imaging of HIV-Infected Patients: Quantitative Analysis of Magnetization Transfer Ratio Histogram and Fractional Brain Volume AJNR Am. J. Neuroradiol., January 1, 2003; 24(1): 82 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ernst, L. Chang, J. Jovicich, N. Ames, and S. Arnold Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients Neurology, November 12, 2002; 59(9): 1343 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-J. von Giesen, H.-J. Wittsack, F. Wenserski, H. Koller, H. Hefter, and G. Arendt Basal Ganglia Metabolite Abnormalities in Minor Motor Disorders Associated With Human Immunodeficiency Virus Type 1 Arch Neurol, August 1, 2001; 58(8): 1281 - 1286. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
